Related references
Note: Only part of the references are listed.Measuring continuous baseline covariate imbalances in clinical trial data
Jody D. Ciolino et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2015)
Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization
Jody Ciolino et al.
CONTEMPORARY CLINICAL TRIALS (2011)
Are Unadjusted Analyses of Clinical Trials Inappropriately Biased Toward the Null?
David M. Kent et al.
STROKE (2009)
Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
Vicki Hertzberg et al.
CLINICAL TRIALS (2008)
Approaches for estimating prevalence ratios
J. A. Deddens et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2008)
Parameter estimation and goodness-of-fit in log binomial regression
L Blizzard et al.
BIOMETRICAL JOURNAL (2006)
Recombinant tissue plasminogen activator (rtPA) for stroke - The perspective at 8 years
JL Frey
NEUROLOGIST (2005)
Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements
AV Hernández et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
TJ Ingall et al.
STROKE (2004)
Tissue plasminogen activator for acute ischemic stroke in clinical practice - A meta-analysis of safety data
GD Graham
STROKE (2003)
The pursuit of balance using stratified and dynamic randomization techniques: An overview
DJ McEntegart
DRUG INFORMATION JOURNAL (2003)
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems
SJ Pocock et al.
STATISTICS IN MEDICINE (2002)
The role of covariates in estimating treatment effects and risk in long-term clinical trials
I Ford et al.
STATISTICS IN MEDICINE (2002)
How to select covariates to include in the analysis of a clinical trial
GM Raab et al.
CONTROLLED CLINICAL TRIALS (2000)
Clinical trials in acute myocardial infarction: Should we adjust for baseline characteristics?
EW Steyerberg et al.
AMERICAN HEART JOURNAL (2000)